Updated 02:01 GMT, 16 Nov 2026 SPX 7,561.67 -0.40% NDX 27,943.74 -1.22% VIX 19.30 +3.21% GOLD 3,876.40 -0.25% CL 88.33 -0.26% BTC 64,613.34 +0.76%
NAS100 27,944 −1.22% S&P 7,562 −0.40% GOLD $3,876 −0.25% BTC $64,613 +0.76% VIX 19.30 +3.21% latest tape · as of 02:01 UTC
The Screen · Consumer Cyclical · Gambling

Churchill Downs Incorporated logoChurchill Downs Incorporated

CHDN · Nasdaq · USD · Market cap $6.8B · 6,600 employees

Churchill Downs Incorporated operates live and historical racing entertainment venues, online wagering businesses, and regional casino gaming properties in the United States.

FAIL · Does not pass the screen
99.72 USD

Price as of 13 Nov 2026Daily close, not a live quote

Screened 2026-11-13 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price99.72 USD at the 13 Nov 2026 close
  • Our value readUndervalued vs our fair value, as of 13 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans to puts (put/call 1.10)
  • Last reviewed13 Nov 2026 (3 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $103.06 to $171.77, base estimate $131.21 (screen dated 2026-11-13).

Current read
Markup ?
Undervalued · screened 2026-11-13
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 1.10, read 2026-11-14
  • Ethical does not pass the values gate
Price99.72 USD
Fair value131.21
Ethical score30.0/100
Value readUndervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-10-21Read Markup81.97+21.7% to today ✓Distribution gives way to Markup after an 8% rise in 3 weeks
2026-10-02Read Distribution76.16+30.9% to today Markup gives way to Distribution after a 16% slide in 5 weeks
2026-08-25Read Markup90.71+9.9% to today ✓Distribution gives way to Markup
2026-07-02Read Distribution86.94+14.7% to today First review on file: Distribution

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Churchill Downs Incorporated holds its Markup at $99.72. The statistical read favours the sellers, held for 8 days.

As held on the ledger · 2026-11-13
PhaseMarkup
Quantitative stateThe statistical read favours the sellers, held for 8 days
Price at the screen$99.72
Valuation15.41 trailing · 13.41 forward price to earnings
Values screenFAIL · score 30.0
Beta0.77
The Workings

Five Screens, Shown in Full

Does not pass. Prohibited keyword in sector/industry: gambling

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Prohibited keyword in sector/industry: gambling Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Churchill Downs does not clear the screen at the business-activity stage. It operates in gambling, so the financial ratios are not the deciding factor here.

Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when CHDN's ethical verdict changes

Today CHDN does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Undervalued vs our fair value, as of 13 Nov 2026: it trades at roughly a 24% discount to our $131.21 fair value, 1.90% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

103.06Conservative131.21Base case171.77Growth case 99.72Price

Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 24.0% discount to the base estimate.

The Street's Range
105.00Street low 125.00Street average 153.00Street high 99.72Price

Third-party analyst targets: 12 covering, consensus Strong Buy. The average target sits +25% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $131.21, with a range of $103.06 to $171.77, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

The racetrack draws crowds but fails the test

Picture the roar at Churchill Downs on derby day, with bets flowing through online platforms and casino floors. The business posts a 35% return on equity and trades at 11.5 times forward earnings, yet none of that matters once the ethical screen flags the entire gambling sector. We pass without hesitation.

Revenue edges up just 3% while profit margins sit at 13%, numbers that look steady on paper. The ethical failure overrides any valuation gap or analyst targets, exactly as the screen is designed to do. No amount of cash generation changes the sector exclusion.

Cyclical exposure to discretionary spending adds real downside when consumer wallets tighten, and the unknown moat leaves little protection if regulation tightens further. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E13.4xexpensive even after accounting for its growth
Trailing P/E15.4xreasonably valued
EPS, trailing6.47
EPS, forward7.44
Revenue growth+1.9%slow but positive growth
Profit margin15.1%healthy profit margins
Return on equity36.8%an exceptional return on shareholder capital
FCF yield4.91%
Dividend yield0.50%
Debt to equity3.42heavy leverage: higher risk if revenue softens
Current ratio0.32below 1: short-term bills exceed liquid assets
Beta0.77steadier than the market
Short interest, float0.08%
52-week range73.09 - 118.35
Market cap$6.8B
Employees6,600

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

CHDN trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-11 Markup $101.96 +4.4% Entry 17

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 4.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (12 analysts) rates it strong buy, with a mean price target of $137.

2026-11-04 Markup $97.65 +19.1% Entry 16

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 19.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (12 analysts) rates it strong buy, with a mean price target of $137.

2026-10-28 Markup $81.97 +0.0% Entry 15

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (12 analysts) rates it strong buy, with a mean price target of $137. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-27 Markup $81.97 +0.0% Entry 14

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (12 analysts) rates it strong buy, with a mean price target of $137. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-26 Markup $81.97 +0.0% Entry 13

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (12 analysts) rates it strong buy, with a mean price target of $137. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-25 Markup $81.97 +0.0% Entry 12

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (12 analysts) rates it strong buy, with a mean price target of $137. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-24 Markup $81.97 +0.0% Entry 11

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (12 analysts) rates it strong buy, with a mean price target of $137. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-23 Markup $81.97 +0.0% Entry 10

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (12 analysts) rates it strong buy, with a mean price target of $137. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-22 Markup $81.97 +0.0% Entry 9

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (12 analysts) rates it strong buy, with a mean price target of $137. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-21 Markup · changed $81.97 +2.5% Entry 8

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 12%. Our forward projection puts the odds of a 10% gain over the next month near 12%. The street (12 analysts) rates it strong buy, with a mean price target of $137. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on CHDN

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in CHDN's Space

Screened names in the same industry · explore each on its own page.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $86.17 +3.5% · $1,035 +3.5%
2 months $87.48 +2.0% · $1,020 +2.0%
3 months $84.08 +6.1% · $1,061 +6.1%
6 months $115.72 -22.9% · $771 -22.9%
1 year $101.45 -12.1% $0.44 $884 -11.6%
2 years $133.60 -33.2% $0.85 $674 -32.6%
3 years $138.20 -35.5% $1.23 $654 -34.6%
5 years $98.88 -9.8% $1.92 $921 -7.9%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever CHDN does next, these words stay.

Churchill Downs Incorporated · CHDN · Markup · $99.72
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.